-
UPDATE: Jefferies Color On Forest Laboratories PT Increase
Monday, May 16, 2011 - 7:28am | 115Jefferies, which raised its PT on shares of Forest Laboratories Inc. (NYSE: FRX), is providing some color on the stock. “FRX has proven its development capability over the last three years and its focus now returns to what it does best – commercial execution. The Street's pessimistic about...
-
Bank Of America Ups PT To $29 On BMY
Monday, May 16, 2011 - 7:22am | 157Bank of America has raised its price target to $29 is maintaining a Neutral rating on Bristol-Myers Squibb Co. (NYSE: BMY), citing a buoy across the major pharma stocks. According to Bank of America, “With each of the four US Major Pharma stocks beating Q1 results and investors beginning to warm...
-
Amylin Pharmaceuticals Files Suit Against Eli Lilly
Monday, May 16, 2011 - 7:11am | 119Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) today announced that it has filed a lawsuit against Eli Lilly and Company (NYSE: LLY) in the United States District Court for the Southern District of California, alleging that Lilly is engaging in anticompetitive activity and breaching its strategic...
-
Mylan Launches First Generic Version of Xibrom Ophthalmic Solution
Monday, May 16, 2011 - 7:03am | 59Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Bromfenac Ophthalmic Solution, 0.09%, based on a development and supply agreement with Coastal Pharmaceuticals. This product is the first generic version of ISTA's Xibrom® Ophthalmic Solution, 0.09...
-
Jefferies Raises PT On Amarin Corporation To $25
Monday, May 16, 2011 - 6:30am | 27Jefferies & Company has raised the price target on Amarin Corporation (NASDAQ: AMRN) from $21 to $25 and maintains its Buy rating.
-
Teva To Acquire 57% Of Taiyo Pharmaceutical Industry for $460 million
Monday, May 16, 2011 - 2:17am | 190Teva Pharmaceutical Industries (NASDAQ: TEVA) announced its plans to acquire 57% of privately-held Taiyo Pharmaceutical Industry for $460 million in cash. Teva reported that it will also make an offer to purchase the remaining shares of Taiyo. The deal is likely to be accretive to GAAP earnings...
-
CEOWORLD Most Promising Top Dividend Stock Picks To Buy Right Now
Sunday, May 15, 2011 - 10:11am | 2008Cognex (CGNX) is trading at a price of $34.86, a dramatic change of -0.97. Currently, the company has a Market capitalization (total value of a company in the stock market) of approximately 1.45B. Cognex is giving up its quarterly distributions by 13% to $0.09 a share. This is the third time over...
-
Yahoo (YHOO) Alibaba Dispute on Alipay, is it legal and 100% transparent?
Saturday, May 14, 2011 - 2:10pm | 1362Yahoo! Inc (YHOO) prized investment in Chinese Internet company Alibaba Group Holding Ltd has turned into a stock market millstone. Alibaba's recently disclosed spinoff of an online-payment unit called Alipay is raising worries about the value of Yahoo's 43 percent stake in Alibaba. Alibaba Group...
-
Stocks Tumble on Inflation Fears, Stronger Dollar
Friday, May 13, 2011 - 2:00pm | 165(TheStreet) -- Stocks were trading nearly 1% lower Friday, driven by rising inflation concerns and a stronger dollar. The Dow Jones Industrial Average was down by 118 points, or 0.9%, at 12,578. The S&P 500 was lower by 12 points, or 0.9%, at 1337, and the Nasdaq was off by 31 points, or 1.1...
-
Biotech/Pharma Stock News Alert: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)
Friday, May 13, 2011 - 1:09pm | 1426Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. (NYSE: MRK) and their...
-
Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)
Friday, May 13, 2011 - 9:00am | 53Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. (NYSE: MRK) and their...
-
Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)
Friday, May 13, 2011 - 9:00am | 53Point Roberts, WA - May 13 2011 - Investorideas.com. a leader in sector stock research including biotech and pharma stocks issues a sector snapshot of three companies, Aethlon Medical, Inc. (OTCBB: AEMD), Vertex Pharmaceuticals Inc. (VRTX), Merck & Company, Inc. (NYSE: MRK) and their...
-
3D Systems Moving to the NYSE
Friday, May 13, 2011 - 8:42am | 753D Systems Corporation (Nasdaq: TDSC) today announced its pending transfer of the listing of its common stock from the NASDAQ Global Select Market to the New York Stock Exchange. The company expects to begin trading on the NYSE on Thursday, May 26, 2011, subject to the satisfactory completion of...
-
Benzinga's Top Pre-Market NASDAQ Losers (NVDA, YHOO, SHOR, BMTI)
Friday, May 13, 2011 - 8:24am | 152NVIDIA Corporation (NASDAQ: NVDA) dipped 6.34% to $19.20 in the pre-market session. NVDA reported upbeat Q1 earnings. Yahoo! Inc (NASDAQ: YHOO) fell 5.77% to $16.18 in the pre-market session. Yahoo! and Softbank were notified by Alibaba Group of two transactions that occurred without the knowledge...
-
J.P. Morgan Comments On BioMemetic Therapeutics Bone Graft Vote
Friday, May 13, 2011 - 7:56am | 94According to J.P. Morgan, BioMimetic Therapeutics (NASDAQ: BMTI) has its work cut out for it. J.P. Morgan said that after a long day of debate, BioMimetic's Augment bone graft received a marginally favorable FDA panel vote Thursday evening. “The panel (n=18) voted on each of: (1) safety; (2)...